"AMBS" - Down today On Funding News - Buying Opportunity
Company now has funds to last 18 months.
Get in today under six cents.
Having operating funds for the next eighteen months puts the company in a much better position when negotiating with Becton Dickinson for a LymPro license agreement and with "big pharma" suitors seeking a development partnership for MANF.
Also organizations and foundations are much more inclined to give grants/funding to companies that they know are financially solvent.